The role and mechanism of claudins in cancer

Bibliographic Details
Title: The role and mechanism of claudins in cancer
Authors: De-Wen Wang, Wei-Han Zhang, Galiullin Danil, Kun Yang, Jian-Kun Hu
Source: Frontiers in Oncology, Vol 12 (2022)
Publisher Information: Frontiers Media S.A., 2022.
Publication Year: 2022
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: claudin, signaling pathways, cancer, molecular targeted therapy, tumor diagnosis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Claudins are a tetraspan membrane protein multigene family that plays a structural and functional role in constructing tight junctions. Claudins perform crucial roles in maintaining cell polarity in epithelial and endothelial cell sheets and controlling paracellular permeability. In the last two decades, increasing evidence indicates that claudin proteins play a major role in controlling paracellular permeability and signaling inside cells. Several types of claudins are dysregulated in various cancers. Depending on where the tumor originated, claudin overexpression or underexpression has been shown to regulate cell proliferation, cell growth, metabolism, metastasis and cell stemness. Epithelial-to-mesenchymal transition is one of the most important functions of claudin proteins in disease progression. However, the exact molecular mechanisms and signaling pathways that explain why claudin proteins are so important to tumorigenesis and progression have not been determined. In addition, claudins are currently being investigated as possible diagnostic and treatment targets. Here, we discuss how claudin-related signaling pathways affect tumorigenesis, tumor progression, and treatment sensitivity.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2234-943X
Relation: https://www.frontiersin.org/articles/10.3389/fonc.2022.1051497/full; https://doaj.org/toc/2234-943X
DOI: 10.3389/fonc.2022.1051497
Access URL: https://doaj.org/article/5df2da937e664178a75108795cd5f3b5
Accession Number: edsdoj.5df2da937e664178a75108795cd5f3b5
Database: Directory of Open Access Journals
More Details
ISSN:2234943X
DOI:10.3389/fonc.2022.1051497
Published in:Frontiers in Oncology
Language:English